Xenon Pharmaceuticals Inc.
XENE | NASDAQ
$37.64
+$0.23 (+0.61%)
Nov 2, 2026, 3:56 PM ET · Market open
90-Day Net Volume
$614.76K
90-Day Activity
2 Buys / 3 Sales
All-Time Net Volume
-$42.74M
Total Filings
983
Insider Trading Activity
| Name | Transaction Date | Transaction Type | Shares | Price | Value |
|---|---|---|---|---|---|
Kelly Thomas Patrick Chief Financial Officer | Sep 30, 2026 | P-Purchase Common Shares | 15,000 | 37.32 | $559,740 |
Mortimer Ian PRESIDENT & CEO | Sep 30, 2026 | P-Purchase Common Shares | 30,000 | 37.38 | $1,121,400 |
Kenney Christopher John Chief Medical Officer | Aug 28, 2026 | S-Sale Common Shares | 6,368 | 60.17 | $383,145 |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove XENE